학술논문

Impact of First Line Antiangiogenic Therapy Duration on Nivolumab Outcome in Metastatic Renal Cell Carcinoma Patients Treated in the GETUG—AFU 26 NIVOREN
Document Type
Article
Source
In: Clinical Genitourinary Cancer. (Clinical Genitourinary Cancer, December 2023, 21(6):643-652)
Subject
Language
English
ISSN
19380682
15587673